Bormioli Pharma, leading pharma packaging manufacturer based in Italy, announces the first sustainable plastic packaging solutions for the pharmaceutical industry.
In a wider scenario where sustainability is among the most relevant topics on the agenda, time has come for businesses to concretely act for the environment. Bormioli Pharma is committed to lead the change in the pharma industry, by promoting the first green plastic solutions compliant with the European Pharmacopoeia and by making sustainability a key topic of the new corporate innovation strategy.
Specifically, Bormioli Pharma has developed a new product: a bottle made of 100% pharma-grade rPET, which features exactly the same performances of its virgin counterpart (PET): the high quality of Bormioli Pharma’s post-consumer recycled PET makes it transformable exactly like the virgin PET, allowing the creation of a highly-customized solution according to customer needs.
The product has also been rated suitable for food contact, featuring an excellent transparency, low levels of contamination, as well as physical and mechanical properties comparable to virgin PET.
The company has also developed cups and spoons in food-grade PLA – fully degradable within 60 days in industrial compost facilities.
